Effect of hydrogen on patients with type 2 diabetic retinopathy

Phase 1

Completed

• Conditions: Type 2 Diabetes Mellitus

• Registration Number: ITMCTR1900002452
• Lead Sponsor: Shanghai University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) The resident population registered in the Shanghai household registration or street, aged 18-70, male or female;
(2) Type 2 diabetes patients included in community management and signed with family doctors;
(3) Patients with type 2 diabetes complicated with retinopathy;
(4) Volunteer to participate in the trial and sign the informed consent form.

Exclusion Criteria

(1) Patients with chronic or old fundus diseases before diabetes;
(2) The average glycated hemoglobin (HbA1c) was over 9% in the past 6 months;
(3) Glomerular filtration rate (eGFR) is under 30 (ml/min/1.73m2);
(4) Patients who use insulin;
(5) Those who are severe smokers or alcoholics;
(6) Patients with chronic liver disease or cardiovascular and cerebrovascular diseases;
(7) Patients with serious diseases such as malignant tumors;
(8) Pregnant women or lactating women;
(9) Those who have had anti-oxidation treatment or participated in similar trials in the past 3 months;
(10) Other situations that the investigator thinks it inappropriate to participate in the trials.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Glycated hemoglobin;